Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them

Martin J. Burton (Lead / Corresponding author), Janet E. Clarkson, Beatriz Goulao, Anne-Marie Glenny, Andrew J. McBain, Anne G. M. Schilder, Katie E. Webster, Helen V. Worthington

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Abstract

Objectives

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the benefits and harms of antimicrobial mouthwashes and nasal sprays administered to patients with suspected or confirmed COVID-19 infection in order to protect the healthcare workers (HCWs) caring for them.

To assess the benefits and harms of antimicrobial mouthwashes and nasal spray in improving outcomes for patients with suspected or confirmed COVID-19 infection.

Original languageEnglish
Article numberCD013627
Pages (from-to)1-9
Number of pages9
JournalCochrane Database of Systematic Reviews
Volume2020
Issue number5
DOIs
Publication statusPublished - 20 May 2020

Fingerprint Dive into the research topics of 'Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them'. Together they form a unique fingerprint.

  • Cite this